Log in to save to my catalogue

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc F...

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc F...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_16109776

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

About this item

Full title

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

Publisher

Boston, MA: Massachusetts Medical Society

Journal title

The New England journal of medicine, 1997-07, Vol.337 (3), p.141-147

Language

English

Formats

Publication information

Publisher

Boston, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

Rheumatoid arthritis is a common disease, and it produces substantial morbidity as well as an increase in mortality.
1

4
Although the causes of rheumatoid arthritis are not fully understood, laboratory and clinical evidence suggests that proinflammatory cytokines, particularly tumor necrosis factor (TNF), have an important role in its...

Alternative Titles

Full title

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_16109776

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_16109776

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJM199707173370301

How to access this item